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INVITED COMMENTARY
A. Ross Naylor MD, FRCS, Leicester, United Kingdom
This is one of the largest single-center series documenting
early and long-term outcomes after carotid angioplasty (CAS) in a
selected group of patients deemed “high-risk” for carotid endar-
terectomy (CEA). In particular, it is one of few published series
with 10-year follow-up data. Although it is inevitable that surgeons
will disagree with some of the criteria deemed to render patients at
higher risk for procedural stroke (asymptomatic atherosclerotic
stenosis, asymptomatic post-CEA restenosis, and asymptomatic
postradiation stenosis), the title of this paper (conveniently) shifts
debate away from patient selection to focus attention on late
results. This is a perfectly reasonable aim, bearing in mind the
skepticism of many surgeons regarding claims that the late results
of CAS are at least equivalent to CEA.
In this respect, the data from this paper clearly suggest that the
risk of long-term stroke after CAS is remarkably low (10-year
freedom from any stroke and ipsilateral stroke was 96% and 98%).
These results are much better than most contemporary surgical
series and represent an improvement on parallel data from the
European Carotid Surgery Trial (ECST), the North American
Symptomatic Carotid Endarterectomy Trial (NASCET), the
Asymptomatic Carotid Atherosclerosis Study (ACAS) and the
Asymptomatic Carotid Surgery Trial (ACST). None of the ran-
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domized trials came close to reporting an annual ipsilateral stroke
risk of 0.2%, although Bergeron et al do cite other studies with
results similar to theirs. Interestingly, the authors have not refer-
enced the Carotid and Vertebral Artery Transluminal Angioplasty
Study (CAVATAS).1Although criticized for its high procedural
risk, the “much maligned” CAVATAS trial is one of the few
randomized studies to have shown that following successful CAS,
there is no significant difference in the risk of late stroke when
compared with CEA.
Notwithstanding the low risk of late stroke, which is actually
the most important end-point to consider, surgeons have also been
critical of apparently higher rates of restenosis after CAS compared
with CEA, citing this as a major limitation for the future. Once
again, the data from Bergeron would seem to suggest that this
concern is unfounded. In their study, cumulative freedom from
restenosis 50% was 1.8%, 3.2%, and 6.8% at 1, 2 and 10 years,
respectively—again, much lower than most contemporary surgical
series. In CAVATAS, CAS patients incurred a 14% risk of restenosis
70% at 1 year compared with 6.7% in CEA patients. Quite why
this difference should be so marked is unknown, but merits further
study.
This paper has not settled issues regarding patient selection
and generalizability (key unresolved issues), but it does contribute
towards an increasing body of evidence that long-term outcomes
are probably no different to CEA.
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